Discounted for Persistent Weakness, Not Opportunity
Bayer trades at a discount for persistent operational weakness, not hidden value. A 2.3% ROIC and 7.1% margin keep pressure on the stock. Regulatory and pricing headwinds hit harder than for peers. Cheap for a reason—this isn’t a turnaround yet.
Published by AssetNext · 2026-06-05
| Date | Signal | Peer score | Drawdown | 21d vs sector |
|---|---|---|---|---|
| 2026-07-17 | Weak profile, strong price | 60 | -9.2% | +24.3% |
| 2026-07-10 | Weak profile, strong price | 59 | -6.1% | +42.6% |
| 2026-07-10 | Weak profile, strong price | 61 | -6.1% | +27.5% |
| 2026-07-03 | Weak profile, strong price | 61 | 0.0% | +34.3% |
| 2026-06-29 | Weak profile, strong price | 58 | -6.4% | +24.2% |
| 2026-06-29 | Weak profile, strong price | 62 | -6.4% | +17.7% |
Break down BAYN.DE's structural position across all peer dimensions with the interactive app.